LifeMD(US:LFMD) ZACKSยท2024-11-08 00:10Company Performance - LifeMD, Inc. reported a quarterly loss of $0.14 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.10, representing an earnings surprise of -40% [1] - The company posted revenues of $53.39 million for the quarter ended September 2024, missing the Zacks Consensus Estimate by 0.26%, but showing an increase from $38.61 million in the same quarter last year [2] - Over the last four quarters, LifeMD has surpassed consensus EPS estimates only once, while it has topped consensus revenue estimates three times [2] Stock Performance - LifeMD shares have declined approximately 39% since the beginning of the year, contrasting with the S&P 500's gain of 24.3% [3] - The current Zacks Rank for LifeMD is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.02 on revenues of $57.63 million, and for the current fiscal year, it is -$0.49 on revenues of $205.5 million [7] - The trend of estimate revisions for LifeMD is mixed, which could change following the recent earnings report [6] Industry Context - The Medical Services industry, to which LifeMD belongs, is currently ranked in the bottom 45% of over 250 Zacks industries, suggesting potential challenges for stock performance [8] - The performance of LifeMD may also be influenced by the overall outlook for the industry [8]